Biobank Equipment Market Report 2026

Biobank Equipment Market Overview

• Biobank Equipment market size has reached to $4.18 billion in 2025 • Expected to grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: The Increasing Demand For Personalized Medicine Is Fueling The Growth Of The Market Due To The Need For Targeted Therapies And Precise Patient Care • Market Trend: Next-Generation Automated Biobank Storage Systems For Enhanced Sample Preservation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biobank Equipment Market?

Biobank equipment is a specialized tool and system that enables the collection, processing, and preservation of biological samples under controlled conditions to ensure long-term integrity. It supports accurate and efficient sample management, maintaining quality for future analysis and research. Biobank equipment enhances data reliability and traceability, facilitating consistent and reproducible scientific outcomes. The main product types of biobank equipment are cryogenic storage systems and alarm and monitoring systems. Cryogenic storage systems are specialized units designed to preserve biological samples at ultra-low temperatures, ensuring long-term stability and integrity. The sample types include blood products, human tissue, umbilical cord blood stem cells, deoxyribonucleic acid (DNA), and cell lines, and storage systems such as automated biobanking systems, manual biobanking systems, hybrid biobanking systems, modular storage systems, and compact storage systems. It is applied in various applications covering regenerative medicine, life science research, clinical research, and others and is used by several end-users comprising biobanks and biorepositories, pharma and biotech companies, academic and research institutes, and hospital and diagnostic centers.

What Is The Biobank Equipment Market Growth Forecast?

The biobank equipment market size is expected to see strong growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to adoption of automated and hybrid biobanking systems, integration of ai and cloud analytics, expansion of regenerative medicine research, rising demand for cell and dna storage, technological innovation in cryogenic systems. Major trends in the forecast period include AI-enhanced sample management systems, iot-enabled cryogenic monitoring, automated biobanking platforms, cloud-based data tracking systems, high-throughput sample storage solutions.

Global Biobank Equipment Market Segmentation

1) By Product: Cryogenic Storage Systems, Alarm And Monitoring Systems 2) By Sample Type: Blood Products, Human Tissue, Umbilical Cord Blood Stem Cells, Deoxyribonucleic Acid (DNA), Cell Lines 3) By Storage System: Automated Biobanking Systems, Manual Biobanking Systems, Hybrid Biobanking Systems, Modular Storage Systems, Compact Storage Systems 4) By Applications: Regenerative Medicine, Life Science Research, Clinical Research, Other Applications 5) By End-User: Biobanks And Biorepositories, Pharma And Biotech Companies, Academic And Research Institutes, Hospital And Diagnostic Centers Subsegments: 1) By Cryogenic Storage Systems: Cryogenic Storage Systems, Liquid Nitrogen Freezers, Ultra-Low Temperature Freezers, Cryogenic Vials, Cryogenic Storage Tanks 2) By Alarm And Monitoring Systems: Alarm And Monitoring Systems, Temperature Monitoring Systems, Humidity Monitoring Systems, Carbon Dioxide (CO2) Monitoring Systems, Remote Alarm Systems, Data Logging Systems

What Is The Driver Of The Biobank Equipment Market?

The increasing demand for personalized medicine is expected to propel the growth of the biobank equipment market going forward. Personalized medicine is an approach to patient care that tailors treatment and prevention strategies based on individual differences in patients' genes, environments, and lifestyles. The growing adoption of personalized medicine is driven by advances in genomic sequencing technologies and data analytics, which enable healthcare providers to develop more precise diagnostic tools and targeted therapies for individual patients. Biobank equipment aids personalized medicine by efficiently preserving and organizing biological samples with critical genetic and molecular information, enabling researchers to examine individual differences, discover biomarkers, and create therapies tailored to each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the biobank equipment industry.

Key Players In The Global Biobank Equipment Market

Major companies operating in the biobank equipment market are Thermo Fisher Scientific Inc., Merck KGaA Darmstadt Germany, Becton Dickinson and Company, Agilent Technologies Inc., Revvity Inc., PHC Holdings Corporation, QIAGEN N.V., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, Hamilton Company, Azenta Life Sciences Inc., Promega Corporation, BioLife Solutions Inc., Standard BioTools Inc., SPT Labtech Ltd, LabVantage Solutions Inc., Izon Science Limited, askion GmbH, Custom Biogenic Systems Inc., Zhongke Meiling Cryogenics Co. Ltd.

Global Biobank Equipment Market Trends and Insights

Major companies operating in the biobank equipment market are focusing on developing next-generation automated storage systems to enhance sample preservation and support the growing demand for personalized medicine. Automated storage systems are advanced solutions that organize, store, and retrieve biological samples using minimal human effort, ensuring precise handling, security, and preservation quality while employing robotics and digital controls to maintain sample integrity and traceability. For instance, in February 2024, Azenta Inc., a US-based provider of life sciences solutions, launched the BioArc Ultra. This next-generation, automated ultracold storage solution provides high-density, eco-friendly sample management for biorepositories. It offers efficient, automated handling of samples at -80°C while using an innovative refrigeration system with zero ozone depletion potential and zero global warming potential. The BioArc Ultra reduces power consumption and space requirements significantly compared to conventional systems, enhancing energy efficiency and sustainability in large-scale biological sample storage operations.

What Are Latest Mergers And Acquisitions In The Biobank Equipment Market?

In November 2024, Standex International Corporation, a US-based industrial growth company, acquired Custom Biogenic Systems for $6.2 million. The acquisition aims to strengthen Standex International’s Scientific business segment by integrating Custom Biogenic Systems’ advanced cryogenic storage and refrigeration solutions. This deal enhances Standex’s presence in the pharmaceutical and biobank markets while broadening its technology portfolio with liquid nitrogen and controlled-rate freezer systems. Custom Biogenic Systems is a US-based manufacturer of biobank equipment.

Regional Outlook

North America was the largest region in the biobank equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Biobank Equipment Market?

The biobank equipment market consists of sales of sample storage freezers, centrifuges, biospecimen tracking systems, and temperature monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.